| Title |
Positive Effects of Soy Lecithin-Derived Phosphatidylserine plus Phosphatidic Acid on Memory, Cognition, Daily Functioning, and Mood in Elderly Patients with Alzheimer’s Disease and Dementia
|
|---|---|
| Published in |
Advances in Therapy, November 2014
|
| DOI | 10.1007/s12325-014-0165-1 |
| Pubmed ID | |
| Authors |
Margret I. Moré, Ulla Freitas, David Rutenberg |
| Abstract |
We report previously unpublished, early pilot studies performed with a brain-health food supplement containing a proprietary blend of 100 mg phosphatidylserine (PS) and 80 mg phosphatidic acid (PA) produced from soy lecithin. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 2 | 17% |
| China | 1 | 8% |
| Australia | 1 | 8% |
| Finland | 1 | 8% |
| United States | 1 | 8% |
| France | 1 | 8% |
| United Kingdom | 1 | 8% |
| Singapore | 1 | 8% |
| Unknown | 3 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 75% |
| Scientists | 2 | 17% |
| Science communicators (journalists, bloggers, editors) | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 248 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Netherlands | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 245 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 35 | 14% |
| Researcher | 32 | 13% |
| Student > Bachelor | 30 | 12% |
| Student > Ph. D. Student | 24 | 10% |
| Other | 23 | 9% |
| Other | 42 | 17% |
| Unknown | 62 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 41 | 17% |
| Nursing and Health Professions | 24 | 10% |
| Psychology | 24 | 10% |
| Agricultural and Biological Sciences | 16 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 6% |
| Other | 52 | 21% |
| Unknown | 75 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2023.
All research outputs
#679,480
of 24,137,435 outputs
Outputs from Advances in Therapy
#63
of 2,479 outputs
Outputs of similar age
#8,816
of 370,678 outputs
Outputs of similar age from Advances in Therapy
#1
of 18 outputs
Altmetric has tracked 24,137,435 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,479 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,678 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.